Hudson Bay Capital Management »

Rani Therapeutics Hldgs shares owned by Hudson Bay Capital Management

Quarter-by-quarter ownership of Rani Therapeutics Hldgs (RANI) shares owned by Hudson Bay Capital Management from 13F filings

Historical chart of Hudson Bay Capital Management investment in Rani Therapeutics Hldgs

Tip: Access up to 7 years of quarterly data

All positions including Rani Therapeutics Hldgs held by Hudson Bay Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rani Therapeutics Hldgs by Hudson Bay Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $113k 153k 0.73

More positions owned by Hudson Bay Capital Management

NVIDIA Corporation Call Option (NVDA)
Tesla Motors Call Option (TSLA)
Amazon Call Option (AMZN)
Apple Call Option (AAPL)
Palantir Technologies Cl A Call Option (PLTR)
Netflix Call Option (NFLX)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Advanced Micro Devices Call Option (AMD)
State Str Spdr S&p 500 Etf T Tr Unit Call Option (SPY)
Berkshire Hathaway Inc Del Cl B New Put Option (BRK.B)
Microsoft Corporation Call Option (MSFT)
Echostar Corp Note 3.875%11/3 (Principal)
Taiwan Semiconductor Manufac Sponsored Ads Put Option (TSM)
Flagstar Bank National Assoc Com New (FLG)
UnitedHealth Put Option (UNH)

View all positions for Hudson Bay Capital Management

Top funds holding Rani Therapeutics Hldgs

RA Capital Management
Samsara BioCapital
AWM Investment Company
Vanguard Group
Vanguard Capital Management
SymBiosis Capital Partners
Longaeva Partners
Susquehanna International
Siren
Geode Capital Management
BlackRock
Nan Fung Group Holdings
683 Capital Management
Vanguard Fiduciary Trust
Millennium Management

View all funds holding Rani Therapeutics Hldgs